Background Clostridium difficile is the leading cause of antibiotic-associated diarrhoea, both
in healthcare facilities and in the community. The recurrence rate of C. difficile infection (CDI) …

Clostridioides difficile infection (CDI) has emerged as a major health problem worldwide. A
major risk factor for disease development is prior antibiotic use, which disrupts the normal …

Clostridioides difficile infection (CDI) is a common healthcare-and antibiotic-associated
diarrheal disease. If mis-diagnosed, or incompletely treated, CDI can have serious, indeed …

Clostridioides difficile infection (CDI) remains a significant contributor to healthcare costs
and morbidity due to high rates of recurrence. Currently, available antibiotic treatment …

Highlights•Antibiotics damage the intestinal microbiota and disrupt colonization resistance
predisposing us to recurrent C. difficile infection (CDI).•Faecal microbiota transplantation …

Background: The recent increase in the number and severity of cases of nosocomial
Clostridium difficile-associated diarrhea (CDAD) has prompted interest in the use of …

Clostridium difficile infections: update on new European recommandations While
metronidazole and vancomycin have been the only drug options to date for the treatment of …

Clostridium difficile is a Gram-positive bacterium with the capacity of spore generation. The
C. difficile infections, related to antibiotic treatment, have increased in number and severity …

Clostridioides difficile infection is the most common cause of infectious diarrhea in hospitals
with an increasing incidence in the community. Clinical presentation of C difficile infection …

There have been a number of advances in probiotics and our understanding of their role in
prevention of CDI, but a number of important safety and efficacy questions remain. An …